HIV & STIs
HIV & STIs 15/10/2009
HPV vaccination of males not cost-effective
Vaccinating boys against human papillomavirus (HPV) in addition to girls is not likely to be cost-effective, conclude a new analysis and an accompanying editorial published online October 8 in the British Medical Journal.
HIV & STIs 02/10/2009
Cancer not cervical cancer vaccine killed UK teen
The pathologist has confirmed that Natalie Morton died from a large malignant tumor of unknown origin in the heart and lungs.
HIV & STIs 29/09/2009
Glaxo's Cervarix vaccine faces delays, concerns
GlaxoSmithKline Plc's bid to sell its Cervarix cervical cancer vaccine in the United States faced further delay on Tuesday and the company recalled a batch of the vaccine in Britain following a teenager's death.
HIV & STIs 29/09/2009
Genital ulcer disease flair-ups in women starting HIV treatment
Roughly 10 percent of the women had genital ulcer symptoms before they started treatment. This increased to 17 percent in the month following treatment initiation, and then dropped back down to 6 percent after the sixth month.
HIV & STIs 19/09/2009
Liver involvement common with syphilis in HIV-infected patients
In a new study, 76% of HIV-infected patients with syphilis had some degree of liver involvement, and in 20%, hepatitis was the presenting symptom of syphilis.
HIV & STIs 10/09/2009
FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKline’s candidate cervical cancer vaccine
CERVARIX was shown to be highly effective and well tolerated in girls and young women for the prevention of cervical pre-cancers and cervical cancer related to human papillomavirus types 16 and 18.
HIV & STIs 10/09/2009
FDA Advisory Committee recommends approval for use of GARDASIL® in boys and men
Committee agrees that clinical data support the efficacy and safety of Merck’s GARDASIL in 9- to 26-year-old boys and men.
HIV & STIs 05/09/2009
Merck's Gardasil seems OK for males: FDA memo
The company is seeking the FDA's permission to market Gardasil for males between 9 and 26 years old, the same age rage currently approved for females.
HIV & STIs 05/09/2009
Young women with STDs at triple risk for HIV infection
Young women between the ages of 13 and 24 years who have been diagnosed with a sexually transmitted disease are approximately 3 times more likely to be diagnosed with HIV in the next 10 years compared with the general age-matched population of women, new research findings suggest.
HIV & STIs 19/08/2009
U.S. researchers see few serious reactions to HPV vaccine
Adverse events like fainting or nausea remain rare among young women and girls given Merck and Co's Gardasil vaccine against cervical cancer, U.S. researchers reported on Tuesday.
HIV & STIs 11/08/2009
Anal cancer survival similar in HIV-positive and HIV-negative people
Standard anal cancer treatment guidelines be followed regardless of HIV status.
HIV & STIs 10/08/2009
Nanoviricides anti-herpes drug candidate reduces viral load by 99.99%
NanoViricides, Inc. has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
HIV & STIs 04/08/2009
New research helps explain why treated genital herpes sores boost risk of HIV infection
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2.
HIV & STIs 29/07/2009
Anal cancer in men with HIV much more common in post-HAART era: could HPV vaccination help?
The annual incidence of anal cancer amongst people with HIV has continued to increase in recent years and now stands at 128 cases per 100,000 or one case in 784 people.
HIV & STIs 15/07/2009
Condoms reduce genital herpes risk
Consistent condom use reduces the risk of genital herpes by 30% compared with never using such protection during sex, researchers said.
HIV & STIs 10/07/2009
WHO clears Glaxo's Cervarix for developing world
WHO green light prerequisite for use in poor countries; Financing issues for vaccine yet to be resolved.
HIV & STIs 07/07/2009
PATRICIA trial shows HPV vaccine effective in prevention of cervical lesions
The final analysis of the PATRICIA study shows that the HPV-16/18 AS04-adjuvanted vaccine (GlaxoSmithKline) has high efficacy against the precancerous cervical lesions that can eventually lead to cervical cancer.
HIV & STIs 12/06/2009
Perianal infection important source of MRSA-associated skin infections
Perianal infection with MRSA is associated with an increased risk of developing skin and soft tissue infections, US investigators report in a study published in the online edition of Clinical Infectious Diseases.
HIV & STIs 01/06/2009
LGV - it's here to stay
The sexually transmitted infection lymphogranuloma venereum (LGV) is here to stay, an editorial in the May 2009 edition of Sexually Transmitted Infections concludes.
HIV & STIs 27/05/2009
GARDASIL® is first cervical cancer vaccine to receive WHO pre-qualification
WHO pre-qualification will help to facilitate expanded global access and implementation of HPV vaccination programs.
More...
